Synthetic cationic antimicrobial peptides bind with their hydrophobic parts to drug site II of human serum albumin
about
Molecular Analysis of AFP and HSA Interactions with PTEN Protein.Anti-dengue virus serotype 2 activity and mode of action of a novel peptide.Identification of a novel cathelicidin antimicrobial peptide from ducks and determination of its functional activity and antibacterial mechanismConjugation of a Dipicolyl Chelate to Polypeptide Conjugates Increases Binding Affinities for Human Serum Albumin and Survival Times in Human Serum.Membrane Active Antimicrobial Peptides: Translating Mechanistic Insights to Design.Antimicrobial efficacy against Pseudomonas aeruginosa biofilm formation in a three-dimensional lung epithelial model and the influence of fetal bovine serum.Comparison of patient-derived high and low phosphatidylserine-exposing colorectal carcinoma cells in their interaction with anti-cancer peptides.Antimicrobial benzodiazepine-based short cationic peptidomimetics.Interaction of human serum albumin with short polyelectrolytes: a study by calorimetry and computer simulations.Staphylokinase has distinct modes of interaction with antimicrobial peptides, modulating its plasminogen-activation properties.Artificial Blood for Dogs.A New Pathway for Protein Haptenation by β-Lactams.Amphiphilic lysine conjugated to tobramycin synergizes legacy antibiotics against wild-type and multidrug-resistant Pseudomonas aeruginosa.Structural basis for alpha fetoprotein-mediated inhibition of caspase-3 activity in hepatocellular carcinoma cells.Short proline-rich lipopeptide potentiates minocycline and rifampicin against multidrug- and extensively drug-resistant Pseudomonas aeruginosa.
P2860
Q35675846-52E9B7A1-6CCA-431D-AA44-6C08C466F4E3Q35739141-4A356DEC-1117-418E-AF12-A6292FD17349Q35853185-2642BE21-E4E5-42CB-8ECC-09CFC3C874DDQ36310984-E3343233-D591-40CE-9C5B-210CCA0453C9Q37639825-F7BABB40-8CD7-46CF-8867-85257B013838Q37679042-63493EBA-1FBC-492D-AED1-D8A0DA886D40Q38722377-3D1331A2-086E-488E-9475-2953BA76976DQ39025458-FD2A470C-6576-4F9D-A484-0228221FA2B0Q40955319-814F57D5-7AC2-478F-8BC9-1B8B37CAF887Q41330788-54348AAB-1EBA-434F-92B7-80270B701373Q42371023-F08FD529-D6DC-47F7-A567-24351E83B123Q47974582-D6FF2A22-393D-4CEF-A985-3502CA6ACB14Q48181255-E7FC0E70-8457-4190-9EDD-88C84654CA83Q48219288-EBBEDB60-5FD1-4831-A2C7-3EA35E112F8DQ50044323-581AE2FE-C53B-49CF-9FDC-8F5CA898AB61
P2860
Synthetic cationic antimicrobial peptides bind with their hydrophobic parts to drug site II of human serum albumin
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Synthetic cationic antimicrobi ...... site II of human serum albumin
@ast
Synthetic cationic antimicrobi ...... site II of human serum albumin
@en
Synthetic cationic antimicrobi ...... site II of human serum albumin
@nl
type
label
Synthetic cationic antimicrobi ...... site II of human serum albumin
@ast
Synthetic cationic antimicrobi ...... site II of human serum albumin
@en
Synthetic cationic antimicrobi ...... site II of human serum albumin
@nl
prefLabel
Synthetic cationic antimicrobi ...... site II of human serum albumin
@ast
Synthetic cationic antimicrobi ...... site II of human serum albumin
@en
Synthetic cationic antimicrobi ...... site II of human serum albumin
@nl
P2860
P50
P3181
P356
P1476
Synthetic cationic antimicrobi ...... site II of human serum albumin
@en
P2093
Annfrid Sivertsen
Johan Svenson
P2860
P2888
P3181
P356
10.1186/1472-6807-14-4
P577
2014-01-23T00:00:00Z
P5875
P6179
1045481530